MedTrace Logo

(SBRT) and (ART) for Pulmonary Metastases From Soft Tissue Sarcomas

NCT01949506 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2023-02-28

Study results available
· View outcomes & findings →

Summary

This is a prospective study to document the local control rates with SBRT specifically for pulmonary metastases from soft tissue sarcoma. This study will prospectively document acute and late toxicity, quality of life (QoL), tumor control, and survival.

Conditions

  • Stage IV Adult Soft Tissue Sarcoma
  • Sarcoma,Soft Tissue

Interventions

RADIATION

SBRT

Stereotactic Body Radiation Therapy

Sponsors & Collaborators

  • Medical College of Wisconsin

    lead OTHER

Principal Investigators

  • Manpreet Bedi, MD · Medical College of Wisconsin

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-24
Primary Completion
2019-10-04
Completion
2019-10-04
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01949506 on ClinicalTrials.gov